These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35786182)

  • 61. Retraction Notice to "Meet the Editorial Board Member".
    Vargo-Gogola T
    Curr Drug Targets; 2022; 23(2):220. PubMed ID: 35139781
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Withdrawal Notice: Obesity: A template to trigger metabolic syndromes and carcinoma. Metformin: A drug target.
    Chandra NC
    Curr Drug Targets; 2021 Apr; ():. PubMed ID: 33906589
    [TBL] [Abstract][Full Text] [Related]  

  • 63. WITHDRAWN: Comparing Nucleated Red Blood Cells in Neonates with and without Retinopathy.
    Boskabadi H; Pourbadakhshan N; Pishghadam E; Zakerihamidi M
    Curr Pediatr Rev; 2021 Sep; ():. PubMed ID: 34503429
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Notice of Withdrawal.
    Curr Rev Clin Exp Pharmacol; 2021 Aug; ():. PubMed ID: 34468304
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Withdrawn: Variations in Altered Global Gene Expression caused by Topoisomerase II Poisons Assessed with Reference to Differences in DNA Binding.
    Zihlif M; Catchpoole DR; Stewart BW; Wakelin LPG
    Curr Mol Pharmacol; 2022 Mar; ():. PubMed ID: 35232357
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Withdrawal Notice: Community-wide Screening of Symptomatic and Asymptomatic Infection of Mycobacterium tuberculosis in the Saharia tribe of India.
    Singh P; Kumar R; Das A
    Comb Chem High Throughput Screen; 2021 Aug; ():. PubMed ID: 34382518
    [TBL] [Abstract][Full Text] [Related]  

  • 67. WITHDRAWN: Scrutinizing the Role of Genetically Modified Herbs (GMHs) in the Treatment of Various Diseases.
    Sindhu RK; Verma R; Salgotra T; Madaan P; Chandel P; Batiha GE; Cavalu S
    Recent Pat Biotechnol; 2022 May; ():. PubMed ID: 35549856
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Withdrawal Notice: Fatal Outcomes from COVID-19 in Diabetes Patients and its Management: Impact of Diabetes and Other Comorbidities in COVID-19.
    Singh S; Bhatt P; Sharma SK; Kaur T
    Curr Diabetes Rev; 2021 Jun; ():. PubMed ID: 34077350
    [TBL] [Abstract][Full Text] [Related]  

  • 69. WITHDRAWN: Anti-lung Cancer Mechanism of Hedyotis Diffusa Willd Based on Network Pharmacology and Molecular Docking.
    Huang F; Xu L; Niu W; Pang J; Li S; Li X
    Comb Chem High Throughput Screen; 2022 Aug; ():. PubMed ID: 36043773
    [TBL] [Abstract][Full Text] [Related]  

  • 70. WITHDRAWN: Expression and Clinical Significance of Cat B and sICAM-1 in the GCF of Patients with Peri-implantitis.
    Lin J; Lin Y; Yu Y; Wang Q
    Recent Pat Nanotechnol; 2023 Aug; ():. PubMed ID: 37594169
    [TBL] [Abstract][Full Text] [Related]  

  • 71. WITHDRAWN: Smart Trends: Liposome-Based Nanocarriers for Cancer Treatment and its Applications.
    Khatoon R; Huda S; Alam MA
    Pharm Nanotechnol; 2022 Feb; ():. PubMed ID: 35142276
    [TBL] [Abstract][Full Text] [Related]  

  • 72. WITHDRAWN: Nucleic Acid-Based Vaccines Platform Against Covid-19 Pandemic.
    Baghban R; Mahmoodi S
    Curr Mol Med; 2022 Jan; ():. PubMed ID: 34994327
    [TBL] [Abstract][Full Text] [Related]  

  • 73. WITHDRAWN: Salmonella typhi: A Review of Antibiogram Journey in Developing Countries.
    Singhal L; Sandhu D; Kour I; Gupta V
    Infect Disord Drug Targets; 2022 Jun; ():. PubMed ID: 35692133
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Withdrawal Notice: Cryptotanshinone Suppresses Liver Fibrosis by Attenuating Epithelial-Mesenchymal Transition through Targeting Hedgehog Pathway.
    Ren S; Yue Q; Wang Q; Zhang Y; Zhang B
    Anticancer Agents Med Chem; 2020 Mar; ():. PubMed ID: 32116202
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Withdrawal Notice: Recent Discovery for Inhibitors Targeting in SARS-CoV-2 and Developed anti-NCP.
    Faheem M; Singh VK
    Mini Rev Med Chem; 2020 Aug; ():. PubMed ID: 32767940
    [TBL] [Abstract][Full Text] [Related]  

  • 76. WITHDRAWN: Impact of Racial Differences on the Epidemiology and Clinical Outcomes of Atrial Fibrillation.
    Quah JX; Dharmaprani D; Tiver K; McGavigan AD; Ganesan AN
    Curr Cardiol Rev; 2021 Dec; ():. PubMed ID: 34886777
    [TBL] [Abstract][Full Text] [Related]  

  • 77. WITHDRAWN: Ivabradine for Uncontrolled Sinus Tachycardia in Thyrotoxic Cardiomyopathy – Case Report.
    Frenkel A; Bichovsky Y; Arotsker N; Besser L; Joshua BZ; Fraenkel M; Zahger D; Klein M
    Endocr Metab Immune Disord Drug Targets; 2021 Sep; ():. PubMed ID: 34544353
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Withdrawal Notice: Overview of Enzyme Engineering Towards the Production of Hyaluronic Acid with Tailored Molecular Weight.
    Ebrahimi T; Hosseini K; Ahangari H; Gholizadeh P; Tarhriz V
    Curr Protein Pept Sci; 2021 Dec; ():. PubMed ID: 34939538
    [TBL] [Abstract][Full Text] [Related]  

  • 79. WITHDRAWN: Toxicity Assessment of Montmorillonite Clay of Western Kazakhstan as a Natural Mineral Sorbent for Animals and Poultry.
    Montayeva NS; Montayev SA; Montayeva AS; Svotina M
    Recent Adv Food Nutr Agric; 2022 Dec; ():. PubMed ID: 36578260
    [TBL] [Abstract][Full Text] [Related]  

  • 80. WITHDRAWN: Imaging Features of Primary Non-Hodgkin’s Lymphoma of Long Bones.
    Han ZW; Wu Y; Han SM; Cao L; Liu C; Yang C; Yang HH; Wu WJ; Gao BL; Yu BH
    Curr Med Imaging; 2023 Feb; ():. PubMed ID: 36733202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.